11/4/2026
Psyence BioMed advances U.S. ibogaine manufacturing
Psyence partners with Benuvia to produce pharmaceutical-grade ibogaine in Texas.
Topic archive
psyence labs ltd.
8 stories
10/5/2026
Psyence BioMed partners with Benuvia for ibogaine production
Agreement aims to produce pharmaceutical-grade ibogaine in Texas facility.
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/28/2026
Psyence secures exclusive U.S. ibogaine license
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
9/23/2026
Psyence BioMed invests $5M in PsyLabs for U.S. ibogaine program
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/23/2026
Psyence and PsyLabs share exchange to boost ibogaine research
Psyence and PsyLabs collaborate to advance ibogaine for opioid use disorder.